Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

GMED – Globus Medical, Inc.

Globus Medical, Inc.
GMED
$71.01
Name : Globus Medical, Inc.
Sector : Healthcare
Industry: Medical Devices
Mark. Cap: $9,766,857,728.00
EPSttm : 0.75
finviz dynamic chart for GMED
Globus Medical, Inc.
$71.01
0.18%
$0.13

Float Short %

2.89

Margin Of Safety %

-3

Put/Call OI Ratio

0.26

EPS Next Q Diff

0.01

EPS Last/This Y

2.66

EPS This/Next Y

0.51

Price

71.01

Target Price

97.46

Analyst Recom

1.59

Performance Q

-21.51

Relative Volume

0.44

Beta

1.3

Ticker: GMED




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-03-21GMED73.570.210.426819
2025-03-24GMED76.040.350.002918
2025-03-25GMED76.660.270.013536
2025-03-26GMED74.350.261.483662
2025-03-27GMED73.620.260.503681
2025-03-28GMED72.540.252.043679
2025-03-31GMED73.180.250.033692
2025-04-01GMED73.390.240.003817
2025-04-02GMED75.570.240.013813
2025-04-03GMED72.020.24999.993847
2025-04-04GMED68.90.263.863918
2025-04-07GMED70.80.250.374051
2025-04-08GMED68.650.250.074068
2025-04-09GMED74.220.251.194077
2025-04-10GMED71.040.264.944092
2025-04-11GMED72.680.260.404103
2025-04-14GMED72.970.270.434280
2025-04-15GMED72.360.270.384299
2025-04-16GMED71.130.270.134304
2025-04-17GMED710.260.154259
2025-04-18GMED71.010.260.154259
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-03-21GMED73.573.9- 3.45
2025-03-24GMED76.063.7- 3.45
2025-03-25GMED76.633.7- 3.45
2025-03-26GMED74.353.7- 3.45
2025-03-27GMED73.623.7- 3.45
2025-03-28GMED72.553.7- 3.45
2025-03-31GMED73.183.7- 3.45
2025-04-01GMED73.393.7- 3.45
2025-04-02GMED75.503.7- 3.45
2025-04-03GMED72.023.7- 3.45
2025-04-04GMED68.903.7- 3.45
2025-04-07GMED70.783.7- 3.45
2025-04-08GMED68.643.7- 3.45
2025-04-09GMED74.203.7- 3.45
2025-04-10GMED71.023.7- 3.45
2025-04-11GMED72.633.4- 3.45
2025-04-14GMED72.983.4- 3.45
2025-04-15GMED72.353.4- 3.45
2025-04-16GMED71.123.3- 3.44
2025-04-17GMED71.013.3- 3.42
2025-04-18GMED71.013.3- 3.42
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-03-21GMED-1.170.712.30
2025-03-24GMED-1.170.642.30
2025-03-25GMED-1.170.642.30
2025-03-26GMED-1.170.642.13
2025-03-27GMED-1.170.642.13
2025-03-28GMED-1.170.642.13
2025-03-31GMED-1.170.652.13
2025-04-01GMED-1.170.652.13
2025-04-02GMED-1.170.652.13
2025-04-03GMED-1.170.652.13
2025-04-04GMED-1.170.652.13
2025-04-07GMED-1.170.692.13
2025-04-08GMED-1.170.692.13
2025-04-09GMED-1.170.692.13
2025-04-10GMED-1.170.692.90
2025-04-11GMED-1.180.692.89
2025-04-14GMED-1.360.712.89
2025-04-15GMED-1.360.712.89
2025-04-16GMED-1.180.712.89
2025-04-17GMED-1.180.712.89
2025-04-18GMED-1.180.712.89
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

0.84

Avg. EPS Est. Current Quarter

0.75

Avg. EPS Est. Next Quarter

0.85

Insider Transactions

-1.18

Institutional Transactions

0.71

Beta

1.3

Average Sales Estimate Current Quarter

629

Average Sales Estimate Next Quarter

682

Fair Value

69.08

Quality Score

81

Growth Score

98

Sentiment Score

66

Actual DrawDown %

25.2

Max Drawdown 5-Year %

-47.9

Target Price

97.46

P/E

95.39

Forward P/E

18.08

PEG

7.74

P/S

4.51

P/B

2.34

P/Free Cash Flow

28.03

EPS

0.74

Average EPS Est. Cur. Y​

3.42

EPS Next Y. (Est.)

3.93

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

4.09

Relative Volume

0.44

Return on Equity vs Sector %

-17.5

Return on Equity vs Industry %

-15.8

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.03

EBIT Estimation

Globus Medical, Inc.
Sector: Healthcare
Industry: Medical Devices
Employees: 5300
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers musculoskeletal solutions, including spine products, such as traditional fusion implants, and treatment options for motion preservation technologies, and interventional solutions to treat vertebral compression fractures; orthopedic trauma solutions, which includes fracture plating, intramedullary nailing, and regenerative biologic products; hip and knee joint solutions, including modular hip stems and acetabular cups for total hip arthroplasty, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants; and neuromonitoring services, which provides onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company also offers enabling technologies, such as imaging, navigation, and robotics (INR) solutions for assisted surgery, which includes the ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures with screw and interbody spacer placement applications; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative, image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cell, tissue, and cellular and tissue-based products. The company sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
stock quote shares GMED – Globus Medical, Inc. Stock Price stock today
news today GMED – Globus Medical, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch GMED – Globus Medical, Inc. yahoo finance google finance
stock history GMED – Globus Medical, Inc. invest stock market
stock prices GMED premarket after hours
ticker GMED fair value insiders trading